GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (BSP:I1DX34) » Definitions » Stock Based Compensation

IDEXX Laboratories (BSP:I1DX34) Stock Based Compensation : R$296 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is IDEXX Laboratories Stock Based Compensation?

IDEXX Laboratories's Stock Based Compensation for the three months ended in Mar. 2024 was R$72 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 was R$296 Mil.


IDEXX Laboratories Stock Based Compensation Historical Data

The historical data trend for IDEXX Laboratories's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEXX Laboratories Stock Based Compensation Chart

IDEXX Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 161.23 159.23 213.53 261.06 292.71

IDEXX Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 72.56 74.55 75.17 74.58 71.71

IDEXX Laboratories Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$296 Mil.


IDEXX Laboratories Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of IDEXX Laboratories's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


IDEXX Laboratories (BSP:I1DX34) Business Description

Traded in Other Exchanges
Address
One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.

IDEXX Laboratories (BSP:I1DX34) Headlines

No Headlines